Article Sidebar
Published:
Mar 6, 2019Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Assessment of maternal deaths due to chronic hypertension: Lessons to learn – a ‘red flag’ for maternal and fetal complications
Abstract
Hypertension, including chronic hypertension and gestational hypertension, is the most common medical complication in pregnancy. Chronic hypertension is associated with up to 5% of all pregnancies and accounts for a significant number of adverse complications, such as superimposed pre-eclampsia, abruptio placentae, iatrogenic preterm labour, stillbirth, small-for-gestational-age fetus and maternal death. To improve care, women with chronic hypertension should seek professional advice before pregnancy. Antihypertensive agents, which are known to cause fetal abnormalities, should be replaced with drugs safe for use in pregnancy. Alternatively, a safe antihypertensive agent should be offered as soon as pregnancy is confirmed. Furthermore, women with chronic hypertension have a 13 - 40% chance of developing superimposed pre-eclampsia and need to be seen more frequently during the antenatal period, either by a specialist or under their supervision.
